At a glance
ClinicalIndex Comparison RecordN/ACompleted· 486 enrolled
Drug / intervention
Enbreldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Etanercept in Iraqi Patients With Moderate to Severe Psoriasis: 5 Years Data From Local Registry.
In Brief
An observational study evaluating Enbrel for Plaque Psoriasis. Completed, enrolled 486 participants across 1 site.
Detailed Summary
This study is to evaluate available local data in Iraqi patients with moderate to severe psoriasis on Enbrel treatment with regards to efficacy, treatment regimen adherence and patient characterization (i.e. age, gender, smoking status) using data from the Dermatologists in Baghdad Teaching Hospital registry
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque Psoriasis
CountriesIraq
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedMay 2020
Enrollment StartJul 2020
Primary CompletionOct 2020
TodayJul 2026
First PostedMay 21, 2020
Enrollment StartJul 5, 2020
Primary CompletionOct 1, 2020
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 6.1 years ago
Interventions
Enbreldrug
As provided in real world practice